Metabolic health assessment

A metabolic health assessment is a clinical evaluation that measures key biomarkers such as blood glucose, triglycerides, HDL cholesterol, blood pressure, and waist circumference to determine metabolic syndrome risk. Insurers use metabolic health assessments to underwrite life insurance policies by quantifying chronic disease risk with data like fasting glucose above 100 mg/dL or triglycerides over 150 mg/dL.

Applicants with optimal metabolic profiles–such as HDL above 40 mg/dL for men and 50 mg/dL for women–typically qualify for preferred rates in term and whole life insurance products. Underwriters request laboratory tests including lipid panels and fasting glucose during the application process to collect objective evidence of metabolic status, according to a report from YourInsurance.info (Your Insurance Info).

Life insurers flag abnormal results from these assessments as indicators of increased mortality risk based on actuarial studies linking poor metabolic health to higher all-cause mortality (e.g. hazard ratio >2). Some companies offer wellness incentives or premium discounts if applicants demonstrate improvements in metrics like reduced waist circumference below 40 inches for men or 35 inches for women.

Metabolic health assessments are required more frequently for applicants aged over 50 or those applying for coverage amounts exceeding $500,000 due to statistically higher prevalence of undiagnosed conditions in these groups. Health insurers may deny coverage or impose exclusions if an assessment reveals uncontrolled diabetes (HbA1c ≥6.5%) or hypertension (systolic BP ≥130 mmHg), citing elevated claims costs documented in CDC morbidity reports.